Dermovate Scalp Application clobetasol propionate

Similar documents
Dermovate Scalp Application clobetasol propionate

Betnovate Scalp Application betamethasone valerate. 1 What Betnovate is and what it is used for. 2 What you need to know before you use Betnovate

Package Leaflet: Information for the User

Dermovate Ointment clobetasol propionate

Dermovate Ointment clobetasol propionate

Eumovate Cream clobetasone butyrate

Eumovate Ointment clobetasone butyrate

Package leaflet: Information for the user. Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin

ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate)

ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Isotrex Gel isotretinoin 0.05% w/w

Daktacort 2% / 1% w/w cream

Package Leaflet Information for the User ILUBE 5% w/v eye drops, solution. Acetylcysteine

Package leaflet: Information for the user. Versatis 700 mg medicated plaster Lidocaine

PATIENT INFORMATION LEAFLET. Hydromol HC Intensive Hydrocortisone and urea

PACKAGE LEAFLET: INFORMATION FOR THE USER. TRAVATAN 40 micrograms/ml eye drops, solution Travoprost

Package leaflet: Information for the user. Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide

PATIENT INFORMATION LEAFLET. Alphaderm 1% & 10% w/w Cream hydrocortisone and urea

DUAL ACTION LOGO. Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate

What is in this leaflet 1. What Dalacin Cream is and what it is used for

Package leaflet: Information for the patient. Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Schollmed Once Weekly Fungal Nail Treatment 5% w/v Medicated Nail Lacquer

Package leaflet: Information for the user. ZORAC 0.05% gel ZORAC 0.1% gel. Tazarotene

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5%

Retin-A 0.05% w/w cream

scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w

PATIENT INFORMATION LEAFLET. Timodine Cream

Occlusal 26%w/w cutaneous solution salicylic acid

O N C E A DAY. In this leaflet FOR WOMEN

Hair Loss Treatment Regular Strength (Minoxidil)

Package leaflet: Information for the user Rogaine 50 mg/g, cutaneous foam. minoxidil

PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin 300 mg Capsules Clindamycin (as hydrochloride)

Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w

Package leaflet: Information for the patient. Duac Once Daily 10mg/g + 50mg/g Gel clindamycin + anhydrous benzoyl peroxide

1 What Gyno-Daktarin cream is and what it is used for

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRAVATAN Z Travoprost Ophthalmic Solution

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vaniqa 11.5% cream Eflornithine

EUMOVATE Clobetasone butyrate 0.05% w/w cream

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5%

Package leaflet: Information for the patient SAFLUTAN 15 micrograms/ml Eye drops, solution in single dose-container. Tafluprost

PATIENT INFORMATION LEAFLET. AMETOP GEL 4% w/w Tetracaine

DP Fusidic Acid Cream

Package leaflet: Information for the user. Vaniqa 11.5% cream Eflornithine

ISOTREX GEL Isotretinoin 0.05% w/w

WOMEN'S Regaine EXTRA STRENGTH

Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults.

Package leaflet: Information for the patient. Onytec 80 mg/g medicated nail lacquer For adults Ciclopirox

Dalacin V Cream Clindamycin phosphate

SIGMACORT cream and ointment

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

Package leaflet: Information for the user. Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam. Minoxidil

EMLA. Prilocaine 2.5%, Lignocaine 2.5% CONSUMER MEDICINE INFORMATION

Consumer Medicine Information. Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g

Package leaflet: Information for the user. Acnatac 10 mg/g mg/g gel clindamycin and tretinoin

PATIENT INFORMATION LEAFLET PUVA TREATMENT. using. Puvasoralen 1.2% Bath Lotion (8-methoxypsoralen)

Information PROPECIA Finasteride 1mg Tablet

Daivobet 50/500 gel Dye-vo-bet

2% w/v Cutaneous Solution Minoxidil PATIENT INFORMATION LEAFLET PANTONE 185 C. 120lpi 0degrees. Black 120lpi 0degrees. Varnish 120lpi 0degrees

ACETOCAUSTIN 0,5 ml, Cutaneous solution

CONSUMER MEDICINE INFORMATION

PACKAGE LEAFLET. EN Elastoplast Heat Plaster 11 mg January

v MM 130.2MM FOR WOME N O N C E A D AY

v02 USER INFORMATION LEAFLET 5% w/v Cutaneous Solution Minoxidil for MEN AND WOMEN 139.7mm 69.85mm 69.85mm 130.2mm Inside Cover CELL SIZE 1mm

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Application of Prescribed Creams/ Ointments/ Lotions (Adult)

A guide for patients who have been prescribed Stelara

Package leaflet: Information for the user. Fredomat 40 microgram/ml oogdruppels, oplossing. Travoprost

PENTAMYCETIN is an antibiotic that: Stops the growth of bacteria Kills bacteria

Package leaflet: Information for the user EMLA Cream 5% (for 30 g surgical packs) lidocaine/prilocaine

Patient Information Leaflet. Dermal Filler

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

Package leaflet: Information for the user. Travoprost Pharmathen 40 microgram/ml, oogdruppels, oplossing Travoprost

Why should you self-care? How can my local pharmacist help? How your pharmacist can help

Skin Reactions from Radiation Treatments

Psoralen Tablets (Methoxypsoralen)

Package leaflet: Information for the patient. Clindamycin ABR 150 mg capsules, hard. Clindamycin ABR 300 mg capsules, hard

Skin Care During Radiation Therapy

PUVA (Psoralen + ultra violet light - wavelength A)

PUVA (Psoralen + ultra violet light - wavelength A)

Administering ORENCIA (abatacept): Your Step-by-Step Guide

Instructions for use. Ixekizumab

The Leeds Teaching Hospitals NHS Trust Whole body PUVA treatment with oral psoralen

Hand and foot PUVA (Psoralen + ultra violet light - wavelength A)

Figure A. Figure B To prevent premature activation of the needle safety guard, do not touch the NEEDLE GUARD ACTIVATION CLIPS at any time during use.

STELARA INJECTION Ustekinumab (rmc) Consumer Medicine Information

Instructions For Use

POLYTAR Plus Liquid PRODUCT INFORMATION. Polytar Plus Liquid medicated scalp cleanser, contains coal tar solution.

Emollient Prescribing Guidelines

Taking Care of Your Skin During Radiation Therapy

ACCUTANE MAKES ME CRY

Care of your skin. Introduction. What can you do to help? Step 1 - Hygiene. Patient Information

Total Skin Electron Beam Therapy (TSEBT)

Instructions For Use PRALUENT (PRAHL-u-ent) (alirocumab) Injection, for Subcutaneous Injection Single-Dose Pre-Filled Pen (75 mg/ml)

EMOLLIENTS. NEW 500g NEW. pump. Up to 37% Wider choice, greater savings! cost savings. without compromising on quality or patient care!

You and your scalp. Helpful hints and advice on treating Dry Scaly Scalp Conditions

COPPERPEX STICK COPPERPEX SUN

ARE YOU? PsA TREAT YOUR SYMPTOMS WITH FOUR DOSES A YEAR. RECOGNIZE THE FOUR SIGNS OF PsA.

HAND DERMATITIS - HOW TO CARE FOR YOUR HANDS

Atopic Dermatitis (Eczema) Allergy and Immunology Awareness Program

Transcription:

Dermovate Scalp Application clobetasol propionate Package Leaflet: Information for the user Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1 What Dermovate is and what it is used for 2 What you need to know before you use Dermovate 3 How to use Dermovate 4 Possible side effects 5 How to store Dermovate 6 Contents of the pack and other information 1. What Dermovate is and what it is used for Dermovate Scalp Application (called Dermovate in this leaflet) contains a medicine called clobetasol propionate. It belongs to a group of medicines called steroids. It helps to reduce swelling and irritation. Dermovate is used to help reduce the redness and itchiness of certain scalp problems. These include frequently relapsing dermatoses and psoriasis that have not responded to milder steroid creams, ointments, lotions or scalp applications. 2. What you need to know before you use Dermovate Do not use Dermovate: if you are allergic (hypersensitive) to clobetasol propionate or any of the other ingredients of this medicine (listed in Section 6) if you have a skin infection on your scalp on a child under 1 year of age. Do not use if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before using Dermovate. Warnings and precautions Talk to your doctor or pharmacist before using your medicine if: you have previously had an allergic reaction with another steroid. you are applying the liquid under an airtight dressing. These dressings make it easier for the active ingredient to pass through the skin. It is possible to accidentally end up using too much. Do not bandage or otherwise cover the treated scalp area, unless directed to do so by your doctor. If directed to cover the treated area with a dressing, make sure that the skin is cleansed before a fresh dressing is applied to prevent infections.

you have psoriasis, your doctor will want to see you more often. you are applying the liquid to broken, damaged or thin skin. you are applying to a large surface area. Contact your doctor if you experience blurred vision or other visual disturbances. If an infection develops during the use of this medicine talk to your doctor or pharmacist. Be very careful not to get the liquid in your eyes. If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before using this medicine. Children Do not use this medicine on a child under the age of 1 year. Avoid continuous treatment for a long period of time in children over the age of 1 year, as their skin is thinner than adults and as a result may absorb larger amounts. Use on children should be limited to a few days and reviewed weekly. Dressings or bandages should not be used on children where the scalp application is applied. Other medicines and Dermovate Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicine, especially if you are taking ritonavir and itraconazole medications. Pregnancy, breast-feeding and fertility If you are pregnant or are breast-feeding, think you may become pregnant or are planning to have a baby ask your doctor or pharmacist for advice before taking this medicine 3. How to use Dermovate Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Using this medicine You usually put Dermovate on your scalp in the morning and at night. This may be reduced as your scalp problem begins to get better, or stopped when it is better. For use on your skin of your scalp only. Do not use it more often than prescribed or use it for a long time (such as every day for many weeks or months). If you need treatment for a long time, your doctor may decide you need to use a milder treatment. The germs that cause infections like warm and moist conditions under dressings. If directed to cover the treated area with a dressing, always clean the skin before

a fresh dressing is put on to help prevent infection of the skin beneath the dressing. Be very careful not to get the liquid in your eyes. Do not touch your eyes until you have washed your hands. If you wash or shampoo your hair it should be dried before applying the liquid. If you are applying the scalp application on someone else make sure you wash your hands after use or wear disposable plastic gloves. This product is flammable. Keep the liquid away from open fire and flames and all sources of ignition, including smoking, during application and immediately after you ve used it. Do not dry your hair with a hairdryer. Guidance on how to apply the liquid 1 Wash your hands. 2 Unscrew the bottle cap and place the nozzle directly on the scalp that needs treating. 3 Gently squeeze the bottle to cover the area with a thin and even layer of liquid. 4 You can rub this liquid in, but you don t have to. Your scalp will feel cool until the liquid has dried. 5 Wash your hands again. 6 Do not exceed the prescribed amount. Use in children Do not use this medicine on children under 1 year of age. It is especially important in children not to exceed the prescribed amount. A course of treatment for a child should not normally last more than a few days, unless your doctor has told you to use it for longer. The doctor may want to see the child every week whilst using Dermovate scalp application. If you use more Dermovate than you should If you apply too much or if accidentally swallowed, it could make you ill. Talk to your doctor or go to hospital as soon as possible. If you forget to use Dermovate If you forget to apply your scalp application, apply it as soon as you remember. If it is close to the time you are next meant to apply it, wait until this time. Do not apply extra Dermovate to make up for a missed dose. If you stop using Dermovate If you use Dermovate regularly make sure you talk to your doctor before you stop using it as your condition may get worse if stopped suddenly. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. Stop using Dermovate and tell your doctor immediately if:

you find that your scalp problem gets worse, you develop a generalised rash or your skin becomes swollen during treatment. You may be allergic to the scalp application, have an infection or need other treatment. you have psoriasis and get raised bumps with pus under the skin. This can happen during or after the treatment and is known as pustular psoriasis. Other side effects you may notice when using Dermovate include: Common (may affect up to 1 in 10 people) a feeling of burning, pain, irritation or itching where the scalp application is applied. Uncommon (may affect up to 1 in 100 people) skin thinning, this may cause stretch marks blood vessels under the surface of your skin may become more noticeable. Very Rare (may affect up to 1 in 10,000 people) Use of Dermovate for a long period of time, or use under an airtight dressing, may cause the following symptoms: increased weight moon face, rounding of the face obesity skin thinning skin wrinkling skin dryness changes to the colour of your skin increased body hair hair loss/lack of hair growth/damaged looking hair Other very rare skin reactions that may occur are: allergic reaction at the site of application worsening of condition application site irritation/pain redness rash or hives if you have psoriasis you may get raised bumps with pus under the skin. This can happen very rarely during or after treatment and is known as pustular psoriasis skin infection acne In children, also look out for the following symptoms: delayed weight gain slow growth Very rare side effects that may show up in blood tests or when your doctor gives you a medical examination: a decrease in the level of the hormone cortisol in your blood increased levels of sugar in your blood or urine

high blood pressure cloudy lens in the eye (cataract) increased pressure in the eye (glaucoma) weakening of the bones through gradual loss of mineral (osteoporosis); additional tests may be needed after your medical examination to confirm if you have this condition Not Known (frequency cannot be estimated from the available data) blurred vision Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Dermovate Keep out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the bottle label or carton after (EXP). The expiry date refers to the last day of that month. Do not store above 30 C. Do not use this bottle for more than 3 months after first opening it. Keep the container tightly closed when not in use. Contents are flammable. Keep away from all sources of fire, flame and heat. Do not leave in direct sunlight. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment. 6. Contents of the pack and other information What Dermovate contains The active ingredient is clobetasol propionate. Each 1 g contains 0.5 mg of clobetasol propionate (0.05% w/w). The other ingredients are carbomer, isopropyl alcohol, sodium hydroxide and purified water What Dermovate looks like and contents of the pack Within each carton is a specially designed plastic bottle with a nozzle and cap that contains 30 or 100 ml of a sticky liquid. Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder: Glaxo Wellcome UK Ltd, Stockley Park West, Uxbridge, Middlesex UB11 1BT Manufacturer: Aspen Bad Oldesloe GmbH, Industriestrasse 32-36, 23843 Bad Oldesloe, Germany

More Information If you have any questions or are not sure about anything, ask your doctor or pharmacist who will advise you. You may be able to find out more information from books in public libraries. Other formats To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge: 0800 198 5000 (UK Only) Please be ready to give the following information: Product name Dermovate Scalp Application Reference number 10949/0046 This is a service provided by the Royal National Institute of Blind People. This leaflet was last revised in September 2017. Trade marks are owned by or licensed to the GSK group of companies. 2017 GSK group of companies or its licensor.